Stockreport

Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206 for Molluscum Contagiosum

Novan, Inc.  (NOVN) 
Last novan, inc. earnings: 11/12 04:23 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.novan.com
PDF Company to hold conference call Friday, January 3, 2020 at 8:30 am Eastern TimeFocus of call: top-line efficacy data and sensitivity analyses MORRISVILLE, N.C., Jan. [Read more]